Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Corcept Therapeutics Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 199 | 3 | 202 | +6 |
| Shares | 80.5M | 28.9K | 80.9M | +390.4K (+0.5%) |
| Value | $1.77B | $636.0K | $1.59B | −$177.3M (−10.0%) |
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Corcept Therapeutics Inc at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (21)
Institutions that held Corcept Therapeutics Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Woodline Partners LP | 213,080 | $4.69M |
| BI Asset Management Fondsmaeglerselskab A/S | 154,761 | $3.40M |
| Alberta Investment Management Corp | 37,100 | $816.0K |
| Allianz Asset Management GmbH | 33,551 | $738.0K |
| Susquehanna International Group, LLP | 28,780 | $633.0K |
| Walleye Capital LLC | 23,514 | $517.0K |
| Jane Street Group, LLC | 21,744 | $478.0K |
| Citadel Advisors LLC | 19,918 | $439.0K |
| Engineers Gate Manager LP | 18,045 | $397.0K |
| AXA S.A. | 13,300 | $293.0K |
| Wealth Architects, LLC | 12,390 | $273.0K |
| Dark Forest Capital Management LP | 10,064 | $221.0K |
| Marshall Wace, LLP | 9,941 | $219.0K |
| First Citizens Bank & Trust Co | 9,495 | $209.0K |
| Camden Capital, LLC | 9,293 | $204.0K |
| Group One Trading, L.P. | 2,764 | $61.0K |
| Walleye Trading LLC | 2,523 | $56.0K |
| Neo Ivy Capital Management | 1,529 | $34.0K |
| Leonteq Securities AG | 1,100 | $24.2K |
| Advisory Services Network, LLC | 200 | $4.00K |
| Bellwether Advisors, LLC | 208 | $4.00K |
Not filed for Q3 2021 yet (3)
Institutions that held Corcept Therapeutics Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Smith Asset Management Group LP | 28,880 | $635.0K |
| CWM, LLC | 37 | $1.00K |
| First Horizon Corp | 14 | $0 |